At diagnosis, approximately 40% of patients had tumors within HAR, and 33.7% experienced recurrent tumors near the hippocampus.
EAU 2025: Debate Oligoprogression after First-Line Systemic Therapy in RCC: A Plea for Local Therapy
Fokas et al. compared stereotactic radiosurgery (SRS), whole-brain radiotherapy (WBRT), and their combination, reporting median overall survival (OS) of 12, 2, and 16 months, respectively, with WBRT ...
All patients received either whole-brain radiotherapy (WBRT) alone, WBRT combined with simultaneous integrated boost (SIB), or fractionated stereotactic radiotherapy (FSRT), with RT doses following ...
The current treatment of brain metastasis is still mainly based on local therapies, which include surgery, stereotactic radiosurgery, and whole-brain radiation therapy (WBRT). Drug therapy showed good ...
After discussion with the patient and her family, the combination of etoposide, methotrexate, actinomycin-D, cyclophosphamide, and vincristine (EMA-CO) chemotherapy and whole brain radiation therapy ...
Background: Thioredoxin reductase (Trx) has been implicated in activation of hypoxia-inducible factor-1α, which is overexpressed in > 85% of renal cell carcinomas (RCCs). We evaluated the safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results